CIK: 0001388551 · Show all filings
Period: Q3 2013 (← Previous) (Next →)
Filing Date: Nov 14, 2013
Total Value ($000): $149,327 (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value ($000) | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| — | SYNTA PHARMACEUTICALS CORP | 23,634,349 | $149,133 | 99.9% | $8.49 | — | COM | 87162T206 |
| — | HALLMARK FINL SVCS INC EC | 21,925 | $194 | 0.1% | $9.39 | — | COM NEW | 40624Q203 |